jiajia LI

Dr. jiajia LI

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JLjiajia LI
jiajia LI
HYHongmei Yang
Hongmei Yang
LZLingyi Zhang
Lingyi Zhang
SZsongling zhang
songling zhang
YDYun Dai
Yun Dai
Cancer cells are usually featured by metabolic adaptations that facilitate their growth, invasion, and metastasis. Thus, reprogramming of intracellular energy metabolism is currently one of the hotspots in the field of cancer research. Whereas aerobic glycolysis (known as the Warburg effect) has long been considered a dominant form of energy metabolism in cancer cells, emerging evidence indicates that other metabolic forms, especially oxidative phosphorylation (OXPHOS), may play a critical role at least in some types of cancer. Of note, women with metabolic syndromes (MetS), including obesity, hyperglycemia, dyslipidemia, and hypertension, have an increased risk of developing endometrial carcinoma (EC), suggesting a close link between metabolism and EC. Interestingly, the metabolic preferences vary among EC cell types, particularly cancer stem cells and chemotherapy-resistant cells. Currently, it is commonly accepted that glycolysis is the main energy provider in EC cells, while OXPHOS is reduced or impaired. Moreover, agents specifically targeting the glycolysis and/or OXPHOS pathways can inhibit tumor cell growth and promote chemosensitization. For example, metformin and weight control not only reduce the incidence of EC but also improve the prognosis of EC patients. In this review, we comprehensively overview the current in-depth understanding of the relationship between metabolism and EC and provide up-to-date insights into the development of novel therapies targeting energy metabolism for auxiliary treatment in combination with chemotherapy for EC, especially those resistant to conventional chemotherapy.

15 February 2021 in Molecules
Verified
Journal Article
Open access
PDF file
FZFeijie Zhao
Feijie Zhao
XCXinxin Ci
Xinxin Ci
XMXiaxia Man
Xiaxia Man
JLjiajia LI
jiajia LI
ZWZhentong Wei
Zhentong Wei
SZsongling zhang
songling zhang
Oxidative stress, which refers to unbalanced accumulation of reactive oxygen species (ROS) levels in cells, has been linked to acute and chronic diseases. Nuclear factor erythroid 2-related factor 2/antioxidant response element (Nrf2/ARE) pathway plays a vital role in regulating cytoprotective genes and enzymes in response to oxidative stress. Therefore, pharmacological regulation of Nrf2/ARE pathway is an effective method to treat several diseases that are mainly characterized by oxidative stress and inflammation. Natural products that counteract oxidative stress by modulating Nrf2 have contributed significantly to disease treatment. In this review, we focus on bioactive compounds derived from food that are Nrf2/ARE pathway regulators and describe the molecular mechanisms for regulating Nrf2 to exert favorable effects in experimental models of diseases.

9 April 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
XWXiaoning Wang
Xiaoning Wang
JLJin Li
Jin Li
WLWeiwei Lu
Weiwei Lu
FGFangbo Gao
Fangbo Gao
SZsongling zhang
songling zhang
JLjiajia LI
jiajia LI
Millions of women worldwide are infertile due to gynecological disorders, including premature ovarian insufficiency, polycystic ovary syndrome, Asherman syndrome, endometrial atrophy, and fallopian tube obstruction. These conditions frequently lead to infertility and have a substantial impact on the quality of life of the affected couples, primarily because of their psychological implications and high financial costs. Recently, using platelets to stimulate cell proliferation and tissue differentiation has emerged as a promising approach in regenerative medicine. Platelet-rich plasma (PRP) shows considerable potential for promoting endometrial hypertrophy and follicle development, making it a promising therapeutic option for tissue repair or replacement. This review provides an overview of the recent advancements and underlying mechanisms of PRP therapy for various female reproductive diseases and presents new therapeutic options for addressing female infertility.

15 May 2025 in Computers in Biology and Medicine
Verified
Journal Article
Open access
XPXiaoqiang Pan
Xiaoqiang Pan
JLjiajia LI
jiajia LI
PLPanbo Liu
Panbo Liu
JLJin Li
Jin Li
MZMingyue Zhao
Mingyue Zhao
SZsongling zhang
songling zhang
Currently, many studies have shown that there is a link between metabolic syndrome (MetS) and endometrial cancer (EC). However, there has been no systematic bibliometric analysis of related publications, which limits the comprehensive understanding of research trends and priorities. Our study makes up for this problem. Through bibliometric analysis, this study aimed to reveal key research focus areas, developmental trends, and major contributors of EC and MetS. The literature for this study was obtained from the Web of Science Core Collection (WoSCC) through August 31, 2024. We searched for EC and MetS using subject and free terms. Microsoft Office Excel 2016, CiteSpace, and VOSviewer software packages were used for bibliometric analysis, considering specific characteristics such as year of publication, country, institution, authorship, journal, references, and keywords. A total of 367 publications were included. Annual publications exhibited exponential growth (R2 = 0.8282), indicatingsustained interest in the field. The United States (111 publications), China (80), and Italy (38) were the most productive countries. The University of California System led institutional contributions. Keyword co-occurrence and burst analysis revealed that obesity (occurrence: 113; link strength: 630), insulin resistance (112; 587), and polycystic ovary syndrome (83; 386) were the most frequent and interconnected research foci. Emerging trends, identified through keyword time-zone mapping (average citation year: 2015-2019), highlighted weight control and bariatric surgery as novel interventions. Journals with the highest impact included ∗Fertility and Sterility∗ (IF: 6.6) and ∗International Journal of Epidemiology (IF: 6.4). This study conducted a preliminary bibliometric and visual analysis of the EC and MetS research literature, revealing trends, global cooperation models, fundamental knowledge, and emerging frontiers of EC and MetS. For over 30 years, research has mainly focused on the correlation between MetS and EC, disease factors, prognosis, prevention, and other aspects that have guiding significance for public health.

29 November 2025 in Cancer Treatment and Research Communications
Verified
Journal Article
Open access
XMXinyu Miao
Xinyu Miao
ZWZhenpeng Wang
Zhenpeng Wang
DLDongzhen Liu
Dongzhen Liu
SJShuyu Ji
Shuyu Ji
JLjiajia LI
jiajia LI
SZsongling zhang
songling zhang
Ovarian cancer remains one of the leading causes of cancer-related mortality among women worldwide. Although standard treatment regimens, including cytoreductive surgery combined with platinum-based chemotherapy, have achieved certain therapeutic advances, the high recurrence rate and the emergence of platinum resistance continue to represent significant clinical challenges. This highlights the urgent need to explore novel therapeutic strategies.As an emerging modality of immunotherapy, PD-1/PD-L1 inhibitors enhance anti-tumor immune responses by modulating the immune system. Although ovarian cancer has traditionally been regarded as a tumor with low immunogenicity, studies have demonstrated that the presence of tumor-infiltrating lymphocytes and the expression of PD-L1 indicate a potential response to immune checkpoint inhibitors.This review focuses on the application of PD-1/PD-L1 inhibitors in the treatment of ovarian cancer, summarizing their mechanisms of action, clinical research progress, potential combination strategies, and future perspectives. A deeper understanding of the role of immune checkpoint inhibitors in ovarian cancer will contribute to optimizing therapeutic strategies and improving patient outcomes. Despite the potential of PD-1/PD-L1 inhibitors in ovarian cancer treatment, overcoming resistance mechanisms, refining patient selection criteria, and improving safety profiles remain key challenges for clinical application.

1 September 2025 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
PLPanbo Liu
Panbo Liu
XMXinyu Miao
Xinyu Miao
QXQiqi Xu
Qiqi Xu
ZLZhuoyao Li
Zhuoyao Li
WLWeiwei Lu
Weiwei Lu
JLjiajia LI
jiajia LI
Background: Cervical adenosquamous carcinoma (ASC) has a poor prognosis, and brain metastasis (BM) is extremely rare. Patients with BM have a poor prognosis. At present, there is no satisfactory treatment and no standard effective treatment. In recent years, immune checkpoint inhibitors (ICIs) and surgical treatment have emerged as a promising treatment for recurrent and metastatic cervical cancer (CC). Case: We report a 39-year-old CC patient whose cervical biopsy pathology showed adenocarcinoma with stage IIIC1r, and so underwent radical radiotherapy and chemotherapy 7 years ago. She was under a palliative enterostomy 4 years ago after intestinal perforation due to multiple recurrence of pelvic tumor. To our surprise, postoperative histopathology was squamous cell carcinoma and adenocarcinoma, ASC was confirmed. The postoperative efficacy of intravenous chemotherapy combined with immunotherapy was partial response (PR), and the efficacy of immunomaintenance therapy was progressive disease (PD). While she had gone through the recurrence of intestinal leakage 3 years ago, Pelvic exenteration (PE) was performed (postoperative histopathology squamous cell carcinoma), the postoperative effect was complete response (CR), and the patient selected regular reexamination. Isolated BM focus was developed in August 2024, and radiotherapy, chemotherapy and immunotherapy were refused after surgical treatment (postoperative histopathology adenocarcinoma). The progression-free survival (PFS) after BM is nearly one year. At present, the patient’s reexamination showed no obvious abnormality. Conclusion: We report a case of ASC, whose at the initial treatment, the cervical lesions were mainly adenocarcinoma. However, pelvic metastatic lesion was mainly squamous carcinoma and underwent chemotherapy combined with immunotherapy combined with PE. The histopathology form of BM is adenocarcinoma. The surgical treatment has achieved remarkable curative effect and survival benefit.The choice of treatment is often based on the number of metastases in the patient’s clinical state, tumor size, and metastases in other organs.